Introduction:Primary central nervous system angiosarcoma is a very rare malignancy, with only 22 cases reported in the literature in the past 26 years. Clinical presentation: A 60-year ... left parietal lobe. Total…
carcinoma. An extensive en-bloc resection was completed, and final pathology indicated high grade angiosarcoma. We detail the imaging and pathological techniques employed that led to this diagnosis. This ... eighth case…
Primary angiosarcoma (AS) of the breast is a rare neoplasia that is not related to radiation exposure. It represents less than 0.05% of all malignant breast tumors. We report ... cases of primary angiosarcoma of the…
Background: Angiosarcomas (AS) are high-grade sarcomas that comprise less than 1% of soft tissue sarcomas. We compared clinical, pathological and molecular features of primary and recurrent conventional AS, including
Angiosarcoma is a rare malignancy of the head and neck. It is usually seen in the elderly, and the prognosis is fatal. Diagnosis can be delayed as a result ... rarity or confounding tissue histology. Here, we report a…
Angiosarcomas are very aggressive, rare malignant tumors that originate from vascular or lymphatic vessels and primarily occur following chemical exposure or radiation therapy. Tumor response to either chemotherapy…
Angiosarcomas of the scalp are a rare and highly aggressive malignant tumor with a poor prognosis. External Beam Radiation Therapy (EBRT) alone has been rarely used for upfront treatment
Sarcomas in irradiated tissues are often considered second cancers and, among these, Angiosarcoma (AS) is an aggressive, malignant endothelialcell tumour of vascular or lymphatic origin. AS can arise
them, only 25% are malignant and nearly 75% are sarcoma and around 40% are angiosarcomas [2]. Sarcomas are often metastatic and have a poor prognosis even after surgical removal with
Background: Though in breast sarcomas angiosarcomas are commonest one, primary breast angiosarcoma accounts only for 0.04% of all malignant breast tumour. Malignant angiosarcomas have inferior prognosis as compared to…
For authors and organisers
Publish, present and keep up with your field
Find the right journal for your paper and submit your manuscript.